Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 22 October 2018 |
| Author/s |
author: Ivan Marquez-Rodas Pier Francesco Ferrucci Piotr Rutkowski Vanna Chiarion Sileni Reinhard Dummer Jedd D. Wolchok Dirk Schadendorf |
| Publication date | October 22, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |